Corynebacterium diphtheriae CRM197 protein

DB16712ApprovedInvestigationalVaccines

Corynebacterium diphtheriae CRM197 protein: Overview.

First approval
Canada, 2010 · United States, 2021 · European Union, 2022
Also known as
Corynebacterium diphtheriae CRM-197 protein · Diphtheria CRM197 protein
Code names
CRM197
Brand names
  • Capvaxive
  • Prevnar 20
  • Vaxneuvance

Resolves to

Compound
UNII08VC9WC084CAS1272033-67-6
Clinical / RWD
RxNorm21748

What you can answer from here — as of August 01, 2026

71Clinical trialsPhase, status and sponsor resolved per trial
Sign in
3Structured indicationsCondition, population, route and combination as fields, not prose
Sign in
14Marketed productsAcross 4 countries and 3 labellers
Sign in

Which other approved drugs treat the same conditions as Corynebacterium diphtheriae CRM197 protein, and which companies have late-stage candidates in those indications?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In